DTI or CLB: Which Is the Better Value Stock Right Now?
DTI vs. CLB: Which Stock Is the Better Value Option?
Zacks
More News
Williams Companies Q2 Earnings & Revenues Miss Estimates, Increase Y/Y
WMB's Q2 earnings and revenues miss estimates but rise year over year as it raises 2026 EBITDA guidance and expands its gas network.
Zacks
Diamondback Energy Q2 Earnings Beat Estimates, Revenues Rise Y/Y
FANG tops Q2 earnings and revenue estimates as higher realized oil prices, production growth and a boosted buyback plan underscore a strong quarter.
Zacks
Is CLB Stock Attractive After Its Sharp Selloff and Mixed Q2 Results?
Core Laboratories stock looks cheaper after a 47.1% six-month selloff, but falling earnings and geopolitical pressure keep the near-term case cautious.
Core Laboratories (CLB) delivered earnings and revenue surprises of +37.50% and -2.31%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
What's in Store for Core Laboratories Stock in Q2 Earnings?
CLB's Q2 may reflect resilient international activity and tariff insulation, but weaker reservoir description results and higher costs could weigh.
Zacks
Earnings Preview: Core Laboratories (CLB) Q2 Earnings Expected to Decline
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
Are Options Traders Betting on a Big Move in Core Laboratory Stock?
Investors need to pay close attention to CLB stock based on the movements in the options market lately.
Zacks
Core Stock Down 39% in 6 Months: Should You Hold or Sell Now?
CLB struggles with ongoing headwinds from lower completion activity, operational disruptions, inflationary costs, weaker margins and projected earnings decline in 2026.